Clinigen Group competitorsClear all

Clinigen Group's top competitors include Paion, ObsEva, Affimed N.V. and Antidote.
Clinigen Group
Clinigen Group
A specialty pharmaceutical and services company with a unique business model dedicated to delivering the right drug to the right patient at the right time
Paion
Paion
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
ObsEva
ObsEva
ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.
Affimed N.V.
Affimed N.V.
Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.
Antidote
Antidote
Antidote is accelerating the breakthroughs of new treatments by bridging the gap between medical research and the people who need them.
Founding Date
Founding Date
2010
Founding Date
2000
Founding Date
2012
Founding Date
2000
Founding Date
2009
Type
Type
Public
Type
Public
Type
Private
Type
Public
Type
Private
Tags
Locations
Locations
Burton upon Trent, GB HQ
Warriewood, AU
Chuo City, JP
Singapore, SG
Pretoria, ZA
Hobson, GB
London, GB
see more
Locations
Aachen, DE HQ
Mönchengladbach, DE
Cambridge, GB
Locations
Plan-les-Ouates, CH HQ
Sacramento, US
Locations
Heidelberg, DE HQ
Locations
London, GB HQ
Carmel, US
New York, US
New York, US
Employees
Employees
1,13342% increase
Employees
3218% decrease
Employees
53
Employees
1371270% increase
Employees
53
Valuation ($)
Valuation ($)
1.1 b
Valuation ($)
192.7 m
Valuation ($)
N/A
Valuation ($)
296.6 m
Valuation ($)
N/A
Twitter followers
Twitter followers
1.4 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
1
Alexa Website Rank
Alexa Website Rank
645582
Alexa Website Rank
733358
Alexa Website Rank
265796
Alexa Website Rank
319782
Alexa Website Rank
323566
Employee Rating
Employee Rating
2.7
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
N/A
Employee Rating
3.7

Financial

Revenue (est.)
Revenue (est.)
£456.9m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
$21.4m (FY, 2019)
Revenue (est.)
£1.5m (FY, 2018)
Cost of goods
Cost of goods
£274.6m (FY, 2019)
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
£1.1m (FY, 2018)
Gross profit
Gross profit
£182.3m (FY, 2019)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
£447.6k (FY, 2018)
Net income
Net income
£5.2m (FY, 2019)
Net income
N/A
Net income
N/A
Net income
($32.4m) (FY, 2019)
Net income
(£5.3m) (FY, 2018)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 60m (almost 5 years ago)
Latest funding round
N/A
Latest funding round
$ 13.5m (over 5 years ago)
Total funding raised
Total funding raised
N/A
Total funding raised
$ 15.2m
Total funding raised
$ 92.9m
Total funding raised
N/A
Total funding raised
$ 17.9m
For sources of this data, please see the company profile

View company profiles

Paion
HQ
Aachen, DE
Employees
32↓ 18% decrease

PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.

View company
ObsEva
HQ
Plan-les-Ouates, CH
Employees
53

ObsEva is a speciality biopharmaceutical company developing drugs for womens reproductive medicine.

View company
Affimed N.V.
HQ
Heidelberg, DE
Employees
137

Affimed is a NASDAQ-listed clinical-stage biopharmaceutical company focused on discovering and developing targeted immuno-oncology therapies.

View company
Antidote
HQ
London, GB
Employees
53

Antidote is accelerating the breakthroughs of new treatments by bridging the gap between medical research and the people who need them.

View company